TBH Global Asset Management’s Novo Nordisk NVO Stock Holding History

TBH Global Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$450K	Hold	9,382	–	–	0.08%	190
2026 Q1	$345K	Buy	9,382 +317	+3%	+$15K	0.07%	204
2025 Q4	$461K	Buy	9,065 +479	+6%	+$24.5K	0.08%	169
2025 Q3	$476K	Buy	8,586 +926	+12%	+$54.2K	0.09%	179
2025 Q2	$529K	Sell	7,660 -97	-1%	-$6.6K	0.11%	124
2025 Q1	$539K	Buy	7,757 +265	+4%	+$21.9K	0.1%	121
2024 Q4	$644K	Buy	7,492 +500	+7%	+$54.1K	0.15%	123
2024 Q3	$833K	Buy	6,992 +710	+11%	+$94.7K	0.18%	112
2024 Q2	$897K	Buy	+6,282	New	+$832K	0.2%	97

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

TBH Global Asset Management's NVO Position: Q2 2026 in Review

TBH Global Asset Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 9,382 shares worth $450K. The position accounts for 0.08% of the portfolio, ranked #190.

TBH Global Asset Management first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $897K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

TBH Global Asset Management held 9,382 shares of Novo Nordisk worth $450K as of Q2 2026.
TBH Global Asset Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.08% of TBH Global Asset Management's portfolio in Q2 2026, its #190 holding.
TBH Global Asset Management first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
TBH Global Asset Management's Novo Nordisk position peaked at $897K in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on TBH Global Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.